9th Oct 2013 11:39
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said that Chief Executive Officer, Andrew Witty, and the following executive directors and managers within the company, were awarded shares on Tuesday, following the notional re-investment of the dividend paid to shareholders on October 3.
The ordinary shares in the company were awarded at a price of 1571 pence per share.
The American Depositary Shares were awarded at a price of USD50.84 per ADS.
Name | Ordinary Shares | ADSs |
Sir Andrew Witty | 17,855.571 |
|
Dr M M Slaoui |
| 5,353.520 |
Mr S Dingemans | 6,924.754 |
|
Mr S M Bicknell | 1,873.095 |
|
Mr R G Connor | 1,241.889 |
|
Mrs D P Connelly |
| 2,258.480 |
Mr S A Hussain | 5,449.411 |
|
Mr W C Louv |
| 1,559.989 |
Mr D S Redfern | 2,675.845 |
|
Ms C Thomas | 3,719.017 |
|
Mr P C Thomson | 1,180.887 |
|
Mr D E Troy |
| 3,008.734 |
Dr P J T Vallance | 6,159.639 |
|
Ms E Walmsley | 3,497.511 |
|
Mr C Weber | 872.878 |
|
Mrs V A Whyte | 438.511 |
|
GlaxosmithKline shares were trading 0.2% higher Wednesday afternoon, at 1,553.00 pence per share.
By Rowena Harris-Doughty; [email protected]; @rharrisdoughty
Copyright © 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Glaxosmithkline